Comparison of the immunogenicity of BM32, a recombinant hypoallergenic B cell epitope–based grass pollen allergy vaccine with allergen extract–based vaccines

類似資料

• Molecular Evolution of Hypoallergenic Hybrid Proteins for Vaccination against Grass Pollen Allergy
  著者:: Linhart, Birgit, 等
  出版事項: (2015)
• Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy
  著者:: Focke-Tejkl, Margarete, 等
  出版事項: (2015)
• Two years of treatment with the recombinant grass pollen allergy vaccine BM32 induces a continuously increasing allergen-specific IgG(4) response
  著者:: Eckl-Dorna, Julia, 等
  出版事項: (2019)
• Skin test evaluation of a novel peptide carrier–based vaccine, BM32, in grass pollen–allergic patients
  著者:: Niederberger, Verena, 等
  出版事項: (2015)
• Mechanisms underlying allergy vaccination with recombinant hypoallergenic allergen derivatives
  著者:: Linhart, Birgit, 等
  出版事項: (2011)